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The functions of membrane proteins are tightly
controlled by the dynamics such as protein traf-
ficking and degradation. We demonstrated that
ligand-directed acyl imidazole (LDAI) chemistry is
broadly applicable to selective chemical labeling of
various types of membrane-bound proteins under
live cell conditions without a need for any tag frag-
ments. The LDAI chemistry enabled pulse-chase
analysis of these proteins to determine the half-life,
as well as their degradation pathways by the imag-
ing, under almost natural cellular conditions.
INTRODUCTION
Membrane proteins comprise one of the main classes of natural
proteins. Their fundamental functions include membrane trans-
port, signal transduction through membranes, chemical conver-
sion on biomembrane surfaces, and intercellular communication
and adhesion, all of which are crucial for sophisticated biological
phenomena. Because membrane proteins play these vital roles,
they represent central targets for modern therapeutics and diag-
nosis (Overington et al., 2006). Therefore, analyzing the structure
and function of membrane proteins in molecular detail is highly
significant for medical and pharmaceutical applications, as
well as for fundamental research. It is now conceivable that the
natural functions of membrane proteins are tightly regulated by
protein dynamics such as protein trafficking and degradation
under living conditions. In most cases, membrane proteins are
constantly internalized and degraded in lysosome. However,
the half-lives of these proteins vary from minutes to days, and
the degradation pathways depend on the type of proteins
and the existing conditions (Ciechanover, 2005). Therefore, valu-
able methods such as pulse-chase analysis or imaging are
greatly desirable for investigating membrane-bound proteins in
intact cellular contexts. Furthermore, such methods require the
general applicability because of the highly diverse structure/
membrane topology in membrane proteins, including peripheral
membrane proteins, lipid-anchored proteins, integral membraneChemistry & Biology 21, 1013–proteins, which have single or multiple transmembrane (TM) do-
mains, and the more complicated membrane proteins made of
oligomeric protein subunits.
Among modern protein studies in live cells, several methods
based on selective protein labeling and imaging, such as green
fluorescent protein (GFP) fusion technology, have been proven
powerful (Lippincott-Schwartz and Patterson, 2003). In recent
years, tag-based technologies including protein or peptide
tags have been actively developed to extend the validation of
protein labeling methods by improving a few limitations of the
GFP method (Chen et al., 2005; Gaietta et al., 2002; Griffin
et al., 1998; Keppler et al., 2003; Los et al., 2008; Mizukami
et al., 2012; Nonaka et al., 2010). Furthermore, bio-orthogonal
chemistry is rapidly growing for protein labeling (Baskin et al.,
2007; Kolb et al., 2001; Li et al., 2011; Song et al., 2008; Spicer
et al., 2012). As a complementary strategy without the use of
labeling tags, we have previously developed ligand-directed to-
syl (LDT) chemistry that represents a tag-free and traceless pro-
tein labeling method that is applicable to endogenous proteins
in live cells (Tamura et al., 2012, 2013; Tsukiji et al., 2009). More
recently, ligand-directed acyl imidazole (LDAI) chemistry exhib-
iting labeling kinetics and amino acid preferences distinct from
the LDT method and in which dihydrofolate reductase (DHFR)
and natural folate receptor (FR) were chemically modified has
been reported (Fujishima et al., 2012; Matsuo et al., 2013).
However, to date, application of LDAI chemistry has been sur-
veyed in a limited manner and the general applicability for
membrane proteins’ labeling in cellular contexts has not been
confirmed.
Here, we demonstrate that LDAI chemistry is broadly appli-
cable to selective chemical labeling of various types of mem-
brane-bound proteins, i.e., integral proteins containing a single
TM or seven TM domains [G protein-coupled receptor (GPCR)],
a ligand-gated ion channel protein composed of tetrameric sub-
units, and a glycosylphosphatidylinositol (GPI)-anchored protein,
under live cell conditions without any tag fragments. More impor-
tantly, pulse-chase analysis of these proteins was successfully
carried out by appropriate proteinmodification using LDAI chem-
istry. The labeling-based biochemical assay allowed us to deter-
mine the protein half-life under almost natural cellular context.
Furthermore, their degradation pathways were also determined
by the live cell imaging.1022, August 14, 2014 ª2014 Elsevier Ltd All rights reserved 1013
Figure 1. LDAI Chemistry for Selective Pro-
tein Modification
(A) Schematic illustration of affinity-based chemi-
cal labeling of membrane proteins. Lg, ligand; Nu,
nucleophilic amino acid.
(B) LDAI reagents used in the present study. 1 and
2 for carbonic anhydrase 12 (CA12); 3 for brady-
kinin B2 receptor (B2R); 4 for NMDA receptor
(NMDAR); 5 and 6 for folate receptor (FR).
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General Strategy forMembrane-Bound Protein Labeling
by LDAI Chemistry in Live Cells
LDAI chemistry is based on a typical nucleophilic acyl substitu-
tion reaction, using the finely tuned reactivity of acyl imidazole
(AI), which is available in aqueous solution (Matsuo et al.,
2013). Like the LDT chemistry that we previously developed
(Tsukiji et al., 2009), LDAI chemistry has been shown to be driven
by the proximity effect and is capable of releasing the ligandmoi-
ety upon covalent labeling of a target protein (Figure 1). The LDAI
labeling reagents were designed as follows: an appropriate
ligand exhibiting a sufficient affinity to targetmembrane proteins,
such as small molecule inhibitors, antagonists, or peptides, was
selected and conjugated to a probe that wewanted to tether with1014 Chemistry & Biology 21, 1013–1022, August 14, 2014 ª2014 Elsevier Ltd All rights resethe target proteins through the AI group.
To evaluate the validity of the LDAI
method, a variety of membrane proteins,
including human carbonic anhydrase 12
(CA12), amembrane-bound enzyme con-
taining a single TM helix (Tu¨reci et al.,
1998); bradykinin B2 receptor (B2R),
which is classified into the family of
GPCRs with seven TM domains (Alla
et al., 1993); N-methyl-D-aspartate
(NMDA) receptor (NMDAR), a gluta-
mate-gated ion channel comprising
tetrameric subunits (Moriyoshi et al.,
1991); and FR, a typical GPI-anchored
protein (Kamen and Capdevila, 1986),
were employed here without introducing
any tags for labeling. All of these proteins
are different from each other in their
membrane topology and size (from 30 to
130 kDa) and are attractive as tumor
biomarkers or drug targets.
Membrane-BoundCA12Labeling in
Live A549 Cells
We initially sought to label endogenous
membrane-bound carbonic anhydrases
(CAs). It is known that a few TM types
of CAs such as CA9 and CA12 are sub-
stantially overexpressed in tumor cells,
particularly under hypoxic conditions,
which makes them valuable biomarkers
for cancer diagnostics and treatment
(Chiche et al., 2009; Ivanov et al., 1998;Wykoff et al., 2000). LDAI labeling reagents 1 and 2 for CAs
were designed with benzenesulfonamide (SA) as the ligand (Su-
puran, 2008; Vullo et al., 2005) for the CA family and a functional
probe such as biotin (Bt) or Oregon green (OG) thorough the AI
linkage. The labeling protocol is quite simple in the LDAI method:
after culturing A549 cells under hypoxic conditions, LDAI reagent
1 in DMSO solution was mixed with A549 cells and incubated for
3 hr, followed by cell washing and lysis, and then the lysateswere
analyzed by western blotting (WB). The anti-CA9 and anti-CA12
WB confirmed that both CA9 and CA12 were overexpressed in
A549 cells under hypoxic conditions. CA12 was strongly stained
by HRP-conjugated streptavidin (SAv-HRP) (lane 2), indicating
efficient biotin labeling of CA12 by LDAI reagent 1, while CA9
was less effectively labeled under these conditions (Figure 2A).
The labeling bands were not detected in the presence ofrved
Figure 2. Endogenous CA Labeling on Live Cells
A549 cells cultivated in hypoxia (<0.1% O2) were treated with 1 (1 mM) in
DMEM (10% FBS) at 37C for 3 hr with or without EZA, a strong inhibitor of CA
(50 mM).
(A) Western blotting analysis using SAv-HRP, mouse anti-CA12 antibody,
rabbit anti-CA9 antibody, and Coomassie brilliant blue (CBB) staining of the
SDS gel. Red arrow head, labeled CA12 and CA9; *, endogenous biotinylated
protein; **, nonspecific band of anti-CA9 antibody.
(B) Structural model of CA12 protein (PDB ID 1JD0). The amino acids (Lys97,
Lys196) modified by 1 are highlighted by red stick models. The zinc ion in the
active site and the acetazolamide inhibitor binding to the active site is shown
as a cyan ball and orange stick model, respectively.
See also Figure S1.
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LDAI-based labeling was driven by ligand-protein recognition
(lane 3). By quantitative examination of the WB band intensity,
we determined that 21% of the endogenous CA12 was labeled
in A549 cells (Figure S1A). We subsequently identified the label-
ing site of CA12 by mass finger printing analysis. By using the
SEQUEST search algorithm, we found the labeled peptide frag-
ments; Lys196 was identified as the labeling site (Figure S1B).
Lys97was also identified as a labeling site, although the resultant
MS score was not sufficiently high. It is noteworthy that both res-
idues are located on the CA12 surface close to the active pocket
(Whittington et al., 2001), explicitly indicating that the high site
selectivity surrounding the ligand-binding pocket, a common
feature of ligand-directed chemistry (Hayashi and Hamachi,
2012; Takaoka et al., 2013), was retained even in live cell condi-
tions (Figure 2B). Furthermore, the amino acid preference wasChemistry & Biology 21, 1013–consistent with our previous report (Lys, Ser, or Tyr) on LDAI
chemistry (Matsuo et al., 2013). These results demonstrated
that labeling of membrane-bound endogenous CAs under live
cell contexts was effectively accomplished by LDAI chemistry.
Time Tracing of CA12 Labeling and Half-Life
Determination in Live Cell Conditions
During the study of endogenous CA12 labeling, we noticed that
the labeled band intensity was strongly dependent on the incu-
bation time. Up to 3 hr incubation, the biotin blotting band inten-
sity increased, but thereafter it gradually decreased until 24 hr
(Figure 3A). This biphasic change suggests that the first incre-
ment step can be attributed to the CA12 labeling and the second
decrease step may be due to the proteolysis or cleavage of the
carbamate bond of the labeled CA. We separately checked the
carbamate bond stability in vitro comparable to the physiological
conditions, i.e., pH and high concentration of GSH (Figures S2A
and S2B available online). Only a minor decrease of the band in-
tensity is detected, which indicates that the decrease of labeled
protein in the second step is attributed to the CA degradation.
To determine the half-life of CA12, we washed out the LDAI re-
agent after 3 hr of labeling andmonitored the change in the band
intensity of labeled CA12. Themonotonic decrease in the labeled
CA12 band was detected with a half-life of 9 hr (Figures 3B and
3D). In contrast, the band intensity did not considerably change
by incubation at 4C (Figure S2C). It should also be pointed out
that the total amount of CA12 never decreased during this time
range in all cases, as confirmed by the anti-CA12 antibody-
stained bands (Figure 3B). Next, the resultant decay profiles of
the labeled CA12 band were compared with the anti-CA12 anti-
body-stained band change in the presence of cyclohexmide
(CHX), an inhibitor of protein biosynthesis in eukaryotic cells,
which is traditionally used to determine the half-life of a protein
(Figure 3C). The decay curve was similar to that of the labeled
CA12 band at 37C, while the almost steady state of the band in-
tensity after the initial decrease (until 6 hr) by CHXwas somewhat
different from the exponential decay of the labeled CA12 (Figures
3C and 3D). This discrepancy may be ascribed to the fact that all
protein synthesis was halted by addition of CHX, which may
confer substantial disturbance to normal live cell habitats. In
contrast, it was clear that our method of using selective CA12 la-
beling by LDAI in live cells enabled us to study the half-life of the
target CA under almost natural conditions.
Pulse-Chase Imaging of the Degradation Process of
Labeled CA12 in Live Cells
Given the modular feature of the LDAI method, a suitable fluoro-
phore such as OG was attached to endogenous CA12 by LDAI
reagent 2 and the fluorescent bio-imaging of CA12 was carried
out using confocal laser scanning microscopy (CLSM). This pro-
vided important information on the endogenous CA12 degrada-
tion pathway in live A549 cells. As shown in the CLSM images
(Figure 4A), strong OG fluorescence was initially detected at
the cell membrane region just after labeling, whereas such im-
ages were not obtained in the presence of the inhibitor EZA
(Figure S3A). After incubation for 3 hr, a few fluorescent granules
appeared inside the cell, and 12 hr later many granules were
observed, predominantly inside the cell, while the fluorescence
became very smeared at the cell membrane region (Figure 4A).1022, August 14, 2014 ª2014 Elsevier Ltd All rights reserved 1015
Figure 3. TimeCourse of CA12 Labeling and
Its Pulse-Chase Analysis
(A) Time course of CA12 labeling on live cell. Top:
schematic illustration of LDAI labeling reaction
followed by its degradation. Bottom: western
blotting using SAv-HRP, mouse anti-CA12 anti-
body, and mouse anti-b actin antibody. Right: The
ratio of labeled-CA12 band intensity during the
LDAI labeling (n = 3; error bar = ± SD). The amount
of labeled CA12 was biphasically changed as
shown in the right panel. A549 cells were treated
with 1 (1 mM) and incubated for 0, 1, 3, 6, 12, and
24 hr in DMEM (10% FBS) at 37C.
(B) Half-life study of CA12 using LDAI pulse-chase
analysis. A549 cells were labeled with 1 (1 mM) for
3 hr and incubated for 0, 3, 6, 12, and 24 hr at 37C
after washing 3 times with the medium. Western
blotting analysis using SAv-HRP, mouse anti-CA12
antibody, and mouse anti-b actin antibody are
shown.
(C) Half-life study of CA12 using CHX chase
analysis. A549 cells were incubated with CHX
(50 mM) in DMEM for 0, 3, 6, 12, and 24 hr at 37C.
Western blotting analysis using mouse anti-CA12
antibody and mouse anti-b actin are shown.
(D) The time course of CA12 degradation. Solid
line, Bt-labeled CA12 degradation at 37C (n = 4);
dashed line, Bt-labeled CA12 degradation at 4C,
(n = 3); dotted line, CHX degradation at 37C
(n = 3) (error bar = ± SD).
See also Figure S2.
Chemistry & Biology
Pulse-Chase Analysis of Membrane Proteins by LDAIThe intracellular fluorescence image showing the OG-labeled
CA12 merged well with that of the fluorescent lysosome marker,
LysoTracker, in many places after 10 hr incubation, revealing
that most of the membrane-bound CA12 was translocated to ly-
sosomes within 10 hr (Figure 4B). Sequential multicolor pulse-
chase imaging was also accomplished by two LDAI reagents
bearing distinct fluorophores, OG (as the first pulse) and Bt/
streptavidin-HiLyte647 (SAv-HiLyte647) (as the second pulse),
which helped elucidate in detail the dynamic trafficking process
in live A549 cells (Figures 4C and S3B). Just after the second
pulse, only OG fluorescent granules were observed inside the
cells. After 3–12 hr, not only green OG spots but also red
(HiLyte647, internalized at a late stage) spots appeared, together
with the yellow spots. The yellow spots generated by overlap-
ping the green and red spots suggest that the endosomes that
were internalized at a late stage were fused with the previously
produced endosome. After 24 hr, the fluorescence on the mem-
brane was scarcely detected and instead red fluorescent spots
were predominantly observed, suggesting that almost all of the
labeled CA12 proteins were internalized and the first labeled
CA12 proteins were degraded.
Based on these imaging data showing that membrane-bound
(OG-labeled) CA12 was internalized via endocytosis followed by
transport to lysosomes, it is reasonable to consider that the
above-mentioned CA12 degradation takes place mainly inside
the lysosome. Indeed, the half-time rate of the endocytosis pro-
cess was estimated to be 9 hr by this time-lapse imaging, which
is identical to that of the degradation decay. In addition, we
confirmed that the degradation of Bt-labeled CA12 was sup-
pressed (half-life of 27 hr) by addition of NH4Cl (20 mM), a lyso-
somal protease inhibitor (Figure S3C). Given these experimental1016 Chemistry & Biology 21, 1013–1022, August 14, 2014 ª2014 Elresults, we demonstrated that the LDAI-based pulse-chase
labeling of membrane-bound CA12 is a useful chemical tool for
evaluating the half-life of a protein in live cells, as well as exam-
ining its degradation process.
Selective Labeling and Pulse-Chase Study of B2R,
NMDAR, and FR in Live Cells by LDAI Chemistry
Oncewehadapotentially useful tool for analyzingmembranepro-
teins’ dynamics, we next sought to extend this method to mem-
brane-bound proteins other than CA12, such as B2R, NMDA
receptor, and FR. Like other GPCRs, B2R, an important drug
target, plays crucial roles in biological events such as vasodilation
and edema (Marceau and Regoli, 2004). Analytical tools for
GPCRs in molecular detail are warranted, although handling
GPCRs isgenerallydifficult becauseof their complicatedphysico-
chemical properties. For B2R labeling, an antagonist peptide
{DArg0[Hyp3,DPhe7,Leu8]BK} (Howl, 1999; Regoli et al., 1998)
wasusedas the ligandpart of LDAI labeling reagent3anda tripep-
tide (HisGlyGly) was newly added at its N terminus where the His
sitewasmodifiedas theAImoiety containing thebiotin probe. The
labelingexperimentwasconductedalmost in thesamemanneras
in the case of CA12; that is, the labeling reagent was mixed with
HEK293 cells expressing B2R, followed by incubation for 3 hr.
The B2R labeling was analyzed byWBanalysis using SAv-HRP
and anti-B2R after the cell lysis. The immature B2R bandswithout
N-glycosylation (I in lanes 1–3, 35 and 40 kDa) and a few of the
mature B2R bands due to the heterogeneous saccharide modifi-
cation (from 50 to 75 kDa) were detected in WB using anti-B2R
(M in lanes 1–3) as shown in Figure 5A (Blaukat et al., 1996; Mich-
ineau et al., 2006). On the other hand, the biotin blotting stained
only the mature bands (Figure 5A, lane 2), revealing selectivesevier Ltd All rights reserved
Figure 4. Pulse-Chase Imaging of Endogenous CA12 on Live Cell
(A) Time-lapse fluorescence imaging of CA12 internalization. The labeling reaction was conducted with 1 mMof 2 in DMEM (10%FBS) at 25C for 3 hr. The labeled
cells were incubated in normoxia at 37C after washing 3 times with themedium. Scale bars, 15 mm. Right panel shows the time profile of the fluorescent intensity
(red, plasma membrane fraction; blue, intracellular fraction) (error bar = ± SD; n = 12).
(B) Colocalization of LysoTracker staining (red) and OG-labeled CA12 (green) at 10 hr incubation. Scale bars, 15 mm. In lower panel, fluorescent intensity of the
dashed line is plotted.
(C) Multicolor pulse-chase imaging of CA12 degradation. The upper panel shows schematic illustration of sequential pulse-chase imaging protocol. The lower
panel shows time-lapse fluorescence images of A549 cells upon labeling with LDAI reagent 2 for first pulse and 1 and SAv-HiLyte647 for second pulse. The
labeling reaction was conducted with 1 mMof 2 in DMEM (10%FBS) at 25C for 3 hr. After 6 hr, the second labeling reaction was conductedwith 1 mMof 1 at 37C
for 3 hr. The labeled cells were stained with SAv-HiLyte647 after washing 3 times with the medium, and incubated in normoxia at 37C. Scale bars, 10 mm.
See also Figure S3.
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the cell surface after posttranslational modification. These broad
bands of the labeled B2R were not detected in the presence of
HOE140 (lane 3), a strong inhibitor of B2R, or in the absence of
B2R transfection (Figure 5A, lane 4), suggesting that the labeling
is extremely selective to the mature B2Rs and nonspecific label-
ing was negligible. The CBB-stained gel pattern with the B2R
transfection (Figure 5A, lanes 1–3) was not apparently different
from that without the B2R transfection (Figure 5A, lane 4), which
means the expression level of B2R was low. It is clear that the
LDAI labeling is applicable to such a low abundant target protein.
The labeled B2R on live cells was also detected by live cell
imaging using complexation of the biotinylated B2R with SAv-
HiLyte647 (Figure S4B), which allowed us to observe the ago-
nist-induced B2R internalization. After the B2R labeling followedChemistry & Biology 21, 1013–by bradykinin addition, the fluorescence on plasma membrane
moved into the cell interior within 20 min, whereas such a rapid
internalizationwas not observed in the case of anHOE140 (antag-
onist) addition (Figure 5B). The rateofbradykinin-induced internal-
ization is almost same as that of previous reports determined by
the radioisotopic ligand (Pizard et al., 1999), strongly indicating
there isno impacton traffickingpropertiesofB2RbyLDAI labeling.
Next, we conducted the half-life study of B2R almost in the
same manner as in the case of CA12. By tracing these labeled
bands, the half-life of B2R was determined to be 8 hr, which is
comparable to that of CA12 (Figures 5C and S4A). From the
time-lapse imaging data in Figure S4C, it is clear that B2R was
internalized within a few hours and concentrated into lysosomes
through endosomes until 6 hr (Figure 5D), similarly to the CA12
endocytosis process mentioned above. It was thus concluded1022, August 14, 2014 ª2014 Elsevier Ltd All rights reserved 1017
Figure 5. B2R Labeling and Pulse-Chase Study Using LDAI Chemistry
(A) B2R labeling on live cells. B2R-translated or vector-translated HEK293 cells were treated with 3 (5 mM) in DMEM at 37
C for 3 hr with or without HOE140
(2.5 mM). The images show western blotting analysis using SAv-HRP, rabbit anti-B2R antibody, and CBB staining of the gel. Red arrow head, labeled B2R; *,
endogenous biotinylated protein; M, mature B2R band; I, immature B2R without N-glycosylation.
(B) Fluorescent imaging of agonist-induced internalization of labeled B2R. Fluorescent images of bradykinin-induced internalization were shown in left panel. In
contrast, the localization of B2R did not mainly change by addition of HOE140 (1 mM) in right panel. Scale bars, 20 mm.
(C) Pulse-chase analysis of B2R. The cells were treatedwith 3 and rinsedwith DMEMand incubated for 0, 1, 3, 6, and 12 hr in DMEMcontaining HOE inhibitor. The
graph represents the time profile of band intensity ratio (n = 3; error bar = ± SD).
(D) Costaining with LysoTracker Green and labeled B2R. B2R expressed on HEK293 cells was biotin-labeled with 3 and stained with SAv-HiLyte647 (red). After
6 hr of incubation, the lysosome was stained with LysoTracker (green). Each color was partially merged. Scale bar, 10 mm. See also Figure S4.
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role in the B2R degradation under live cell conditions.
NMDAR is a huge membrane protein comprising homo- or
heterotetrameric subunits, including GluN1, GluN2A-D, GluN3A,
that is involved in excitatory neurotransmission, brain develop-
ment, and synaptic plasticity associated with memory formation
(Paoletti et al., 2013). Among several NMDAR subunits, we here
employed the GluN1 subunit, which is a crucial subunit for form-
ing a functional homotetramer. For GluN1 labeling in HEK293T
cells (Grimwood et al., 1995), we employed GV150526, a selec-
tive antagonist of the GluN1 subunit (Di Fabio et al., 1997) as the
ligand part, whichwas attached toOG via the AI unit to yield LDAI
reagent 4. WB analysis using anti-fluorescein (FL) antibody,
which has affinity with Oregon green dye, showed that GluN1
was selectively modified with OG, whereas the labeling band
was largely diminished in the presence of GV150526 or in cells1018 Chemistry & Biology 21, 1013–1022, August 14, 2014 ª2014 Ellacking GluN1, clearly implying that LDAI chemistry was appli-
cable to selective labeling of oligomeric membrane-bound pro-
teins with huge molecular weights (Figure 6A). Similarly to the
above two examples, the WB band of the labeled NMDAR grad-
ually decreased in intensity; hence the half-life was estimated to
be 7 hr (Figures 6B and S5A).
Using the same method, the degradation of FR labeled by
LDAI reagent 5 in live human KB carcinoma cells endogenously
expressing FRwas successfully monitored, determining the half-
life to be 42 hr (Figure 6C). This was in good agreement with the
previously reported value, which was evaluated by the isotope
pulse-labeling method and the CHX method (Kane et al.,
1986), indicating that there are no substantial effects on the FR
half-life by LDAI labeling. Its half-life was 5-fold longer than
that of CA12, B2R, and NMDAR. We thus carefully monitored
the dynamics of endogenous FR by attaching an imaging probesevier Ltd All rights reserved
Figure 6. Selective Labeling and Pulse-Chase Study of GluN1 and FR
(A) GluN1 labeling on HEK293T cells. GluN1-translated or vector-translated HEK293T cells were treated with reagent 4 (0.3 mM) in MEM at 37C for 3 hr with or
without GV150526 (1.5 mM). The images show western blotting analysis using rabbit anti-FL antibody, rabbit anti-GluN1 antibody, and silver staining of the gel.
(B) Time profile of degradation of labeled GluN1 and FR (error bar = ±SD; n = 4 for GluN1 and n = 3 for FR).
(C) Pulse-chase analysis and secretion of FR. Labeled FR in cell lysate was analyzed by western blotting using SAv-HRP. Secreted FBD in the medium was
immunopricitated by anti-folate receptor antibody and detected by western blotting using SAv-HRP.
See also Figure S5.
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Pulse-Chase Analysis of Membrane Proteins by LDAI(FL) by LDAI reagent 6, showing that the fluorescence intensity of
the whole cells gradually decreased in the time range coincident
with theWB analysis data (Figure S5B). However, the subcellular
distribution of the fluorescence between the plasma membrane
and the cell interior did not substantially alter for 24 hr. This was
in sharp contrast to the other cases, suggesting that the main
degradation pathway of FR is not attributed to lysosomal degra-
dation. On the basis of previous reports that FR on KB cell mem-
branes was converted to a soluble folate binding domain (FBD)
by a membrane-associated metalloprotease (Elwood et al.,
1991; Yang et al., 1996), we decided to evaluate the content of
the cleaved FBD during our pulse-chase experiments. By col-
lecting the medium and immunoprecipitating the soluble FBD
by an anti-FR antibody, the FBD band was detected from the
medium by biotin blotting and its intensity increased during the
incubation (Figure 6C). This implies that the biotin-labeled FR
on live KB cell membranes was secreted to the medium by pro-
tease cleavage, which may be assigned as the main pathway of
FR degradation.
SIGNIFICANCE
It is clearly demonstrated here that LDAI chemistry-based
protein labeling can be broadly applied to diversemembrane
proteins from rather simple proteins such as GPI- or single
TM-anchored proteins to the more complicated GPCR and
oligomeric receptor proteins such as a glutamic acid-gated
NMDAR. Moreover, the pulse-chase LDAI labeling allowed
us to determine the protein half-life, as well as to examine
its degradation pathway, by combining biochemical WB
analysis and live cell imaging (Figure 7). Protein half-life
has been conventionally evaluated by isotope pulse-chase
labeling or by protein synthesis inhibition (Hare and Taylor,
1991; Jansens and Braakman, 2003). More recently, K.
Johnsson’s group developed a novel method based on
protein labeling using SNAP-tag (Bojkowska et al., 2011).
Compared with such techniques, methods based on natural
protein labeling represent several advantages: (1) radio-
isotope free, (2) no need for a (bulky protein) tag, which isChemistry & Biology 21, 1013–applicable to endogenous proteins, and (3) almost maintain-
ing the natural cellular habitats with minimal perturbation.
As a pioneering example, Cravatt and coworkers have
recently reported such an approach using their activity-
based protein profiling (Chang et al., 2012). The present
study revealed the generality and extended the applicability
of ligand-directed chemistry as a tool for understanding the
dynamics of membrane proteins in live cells. We envision
that a more precise analysis of a variety of membrane pro-
teins that are substantially complicated in their structure
and functions would be facilitated by LDAI chemistry.
EXPERIMENTAL PROCEDURES
General Materials and Methods for Biochemical/Biological
Experiments
SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and western blotting
were carried out using a Bio-Rad Mini-Protean III electrophoresis apparatus.
Chemiluminescent signals generated with Chemi-Lumi One (nacalai tesque)
or ECL Prime (GE Healthcare) were detected with an LAS4000 imaging system
(Fuji Film). Cell imaging was performed with a confocal laser scanning micro-
scope (CLSM, Olympus, FV1000, IX81) equipped with a 603 objective lens.
Fluorescence images were acquired using a 488 nm line of an argon laser
for excitation of Oregon green or fluorescein (emission, 500–600 nm) and a
633 nm line of a HeNe Red laser for excitation of streptavidin modified with
HiLyte647 (SAv-HiLyte647) (emission, 645–745 nm).
Labeling of Endogenous CA12 or FR on Live Cells and Their
Half-Life Studies
A549 cells or KB cells were maintained in 5%CO2 at 37
C in DMEM (Sigma for
A549 cells) or folate free RPMI1640 (GIBCO for KB cells) supplemented with
10% fetal bovine serum (FBS), penicillin (100 units/ml), streptomycin
(100 mg/ml), and amphotericin B (250 ng/ml). For the endogenous CA12 label-
ing, A549 cells (1 3 105 cells) were incubated under the hypoxic condition
(<0.1% O2) generated with AnaeroPack (Mitsubishi Gas Chemical Company)
for 1 day and treated with 1 (1 mM) at 37C in DMEM (10% FBS) for 3 hr in hyp-
oxic condition. As a control experiment, the labeling was conducted in the
presence of EZA (50 mM). For half-life study, the labeled cells were washed
3 times with the same medium, and incubated for 0, 3, 6, 12, an 24 hr in norm-
xia condition and lysed using NP40 buffer (pH 7.4; 50 mM Tris-HCl, 150 mM
NaCl, 1% Nonidet P-40) containing 1% protease inhibitor cocktail set III (Cal-
biochem). The insoluble material was removed by centrifugation at 12,000 rpm
for 10 min. The supernatant was mixed with the same volume of 23 Laemmli1022, August 14, 2014 ª2014 Elsevier Ltd All rights reserved 1019
Figure 7. Schematic Illustration of the Degradation Pathway of
Labeled CA12, B2R, NMDAR and the Secretion of Labeled FR
The labeled CA12, B2R and NMDAR are degraded in lysosome. The half-life is
9 hr (CA12), 8 hr (B2R), and 7 hr (NMDAR). The labeled FR is secreted from the
plasma membrane to the medium and the half-life is 42 hr (FR).
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Pulse-Chase Analysis of Membrane Proteins by LDAIbuffer (pH 6.8; 125 mM Tris-HCl, 20% glycerol, 4% SDS, 0.01% bromophenol
blue, 100 mM dithiothreitol) and incubated for 1 hr at room temperature. The
samples were subjected to SDS-PAGE (10%) and then electrotransferred
onto an Immun-Blot PVDF membrane (Bio-Rad). The biotin-labeled CA12
was detected by chemiluminescence analysis using SAv-HRP (Invitrogen,
310,000). The immunodetection of CA12 was performed with a mouse anti-
CA12 antibody (Abcam, 3500) and anti-mouse IgG-HRP conjugate (GE
Healthcare, 32,000).
For the FR labeling, KB cells (13 105 cells) were treatedwith 5 (1 mM) at 37C
in RPMI1640 (10% FBS) for 3 hr. The cells were washed 3 times with the me-
dium, incubated for 0, 3, 6, 12, and 24 hr, and subjected to western blotting for
protein half-life study. The culture medium (1 ml) was collected, precleared
with protein G agarose resin (Invitrogen, 50 ml), and the cleaved FBD was
immunoprecipitated by using mouse anti-FR antibody (abcam, 32,000) and
protein G agarose resin. The cells were lysed with Ripa buffer (pH 7.6,
25 mM Tris-HCl, 150 mM NaCl, 0.1% SDS, 1% Nonidet P-40) containing
1% protease inhibitor cocktail set III, mixed with the same volume of 23
Laemmli buffer, and subjected to SDS-PAGE and western blotting. The
biotin-labeled FR or FBD was detected by chemiluminescence analysis using
SAv-HRP (Invitrogen, 310,000). b-actin, detected by an antibody (abcam,
32,000), was used as a loading control.
Cycloheximide Degradation Assay
A549 cells (1 3 105 cells) were treated with Cycloheximide (50 mM) at 37C in
DMEM (10% FBS) for 0, 3, 6, 12, and 24 hr and washed with PBS (-). For west-
ern blotting, the cells were lysed using NP40 buffer containing 1% protease in-
hibitor cocktail set III. The lysed sample was centrifuged and the total amount
of protein in supernatant was analyzed by BCA assay. The samples were
diluted to 0.25 mg (total protein)/ml and subjected to WB analysis.
Cell Culture and Transfection of B2R or NMDAR cDNA
The expression plasmid for human B2R, pCI(B2R) was previously constructed
(Nonaka et al., 2010). The expression plasmid for rat GluN1, pTracer (GluN1)
was kindly gifted from Dr. M. Yuzaki (Keio University, Japan). Human embry-
onic kidney (HEK293) or HEK293T cells were maintained in 5% CO2 at 37
C
in DMEM supplemented with 10% FBS, penicillin (100 units/ml), streptomycin
(100 mg/ml), and amphotericin B (250 ng/ml). Transfection of cDNA plasmid
was carried out in a 35 mm dish using Lipofectamine 2000 (Invitrogen) accord-
ing to a general protocol. HEK293 cells were used for B2R transfection and1020 Chemistry & Biology 21, 1013–1022, August 14, 2014 ª2014 Elsubjected to labeling experiments after 48 hr of the transfection. HEK293T
cells were transfected with NMDAR and incubated for 48 hr in MEM with
(5S,10R)-(+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine
(MK-801) (100 mM) to protect the cells from the NMDA receptor-mediated
toxicity.
Labeling of B2R or NMDAR and Their Half-Life Studies
The B2R expressing on HEK293 cells were labeled by the treatment with 1 ml
DMEM containing 5 mM of reagent 3 for 3 hr in 5% CO2 at 37
C. As a control
experiment, the labeling was conducted in the presence of HOE140 (5 mM). For
pulse chase analysis, the cells were washed with DMEM 3 times after
removing the probe solution and incubated in DMEM with HOE140 (1 mM)
for 0, 1, 3, 6, and 12 hr. The dishes were washed with 1 ml HBS 3 times and
lysed with Ripa buffer containing 1% protease inhibitor cocktail set III. After
mixing with the same volume of 23 Laemmli buffer, the following electropho-
resis processes were similarly performed as described above. The immunode-
tection of B2R was performed with a rabbit anti-B2R antibody (Santa Cruz,
3500) and anti-rabbit IgG-HRP conjugate (Santa Cruz, 35,000). For the
pulse-chase imaging, HEK293 cells stably expressing human B2R (Wang
et al., 2011) were used. The cells were labeled with reagent 3 for 3 hr in
DMEM. After the incubation, the cells were washed with DMEM 3 times and
stained using SAv-HiLyte647.
The GluN1 expressing on HEK293T cells were labeled by 0.3 mM of reagent
4 for 3 hr in 1 ml MEM at 37C. As a control experiment, the labeling was con-
ducted in the presence of GV150526 (1.5 mM). After removing the probe so-
lution, the cells were washed with MEM for 3 times and incubated in MEM
containing MK-801 (100 mM) for 0, 3, 6, 10, and 24 hr, lysed and subjected
to SDS-PAGE (7.5%), and transferred to PVDF membrane. The Oregon
green-labeled GluN1 was detected by chemiluminescence analysis using
rabbit anti-fluorescein antibody (abcam, 310,000) and anti-rabbit IgG-HRP.
The immunodetection of GluN1 was performed with a rabbit anti-GluN1 anti-
body (Cell Signaling, 31,000) and anti-rabbit IgG-HRP conjugate (Santa
Cruz, 32,000).SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and five figures and can be found with this article online at http://dx.doi.org/
10.1016/j.chembiol.2014.07.013.
ACKNOWLEDGMENTS
Takayuki Miki acknowledges the Japan Society for Promotion of Science
(JSPS) Fellowships for Young Scientists.
Received: May 14, 2014
Revised: July 11, 2014
Accepted: July 30, 2014
Published: August 14, 2014
REFERENCES
Alla, S.A., Buschko, J., Quitterer, U., Maidhof, A., Haasemann, M., Breipohl,
G., Knolle, J., and Mu¨ller-Esterl, W. (1993). Structural features of the human
bradykinin B2 receptor probed by agonists, antagonists, and anti-idiotypic an-
tibodies. J. Biol. Chem. 268, 17277–17285.
Baskin, J.M., Prescher, J.A., Laughlin, S.T., Agard, N.J., Chang, P.V., Miller,
I.A., Lo, A., Codelli, J.A., and Bertozzi, C.R. (2007). Copper-free click chem-
istry for dynamic in vivo imaging. Proc. Natl. Acad. Sci. USA 104, 16793–
16797.
Blaukat, A., Alla, S.A., Lohse, M.J., and Mu¨ller-Esterl, W. (1996). Ligand-
induced phosphorylation/dephosphorylation of the endogenous bradykinin
B2 receptor from human fibroblasts. J. Biol. Chem. 271, 32366–32374.
Bojkowska, K., Santoni de Sio, F., Barde, I., Offner, S., Verp, S., Heinis, C.,
Johnsson, K., and Trono, D. (2011). Measuring in vivo protein half-life.
Chem. Biol. 18, 805–815.sevier Ltd All rights reserved
Chemistry & Biology
Pulse-Chase Analysis of Membrane Proteins by LDAIChang, J.W., Moellering, R.E., and Cravatt, B.F. (2012). An activity-based im-
aging probe for the integral membrane hydrolase KIAA1363. Angew. Chem.
Int. Ed. Engl. 51, 966–970.
Chen, I., Howarth, M., Lin, W., and Ting, A.Y. (2005). Site-specific labeling of
cell surface proteins with biophysical probes using biotin ligase. Nat.
Methods 2, 99–104.
Chiche, J., Ilc, K., Laferrie`re, J., Trottier, E., Dayan, F., Mazure, N.M., Brahimi-
Horn, M.C., and Pouysse´gur, J. (2009). Hypoxia-inducible carbonic anhydrase
IX and XII promote tumor cell growth by counteracting acidosis through the
regulation of the intracellular pH. Cancer Res. 69, 358–368.
Ciechanover, A. (2005). Proteolysis: from the lysosome to ubiquitin and the
proteasome. Nat. Rev. Mol. Cell Biol. 6, 79–87.
Di Fabio, R., Capelli, A.M., Conti, N., Cugola, A., Donati, D., Feriani, A.,
Gastaldi, P., Gaviraghi, G., Hewkin, C.T., Micheli, F., et al. (1997).
Substituted indole-2-carboxylates as in vivo potent antagonists acting as the
strychnine-insensitive glycine binding site. J. Med. Chem. 40, 841–850.
Elwood, P.C., Deutsch, J.C., and Kolhouse, J.F. (1991). The conversion of the
human membrane-associated folate binding protein (folate receptor) to the
soluble folate binding protein by a membrane-associated metalloprotease.
J. Biol. Chem. 266, 2346–2353.
Fujishima, S.H., Yasui, R., Miki, T., Ojida, A., and Hamachi, I. (2012). Ligand-
directed acyl imidazole chemistry for labeling of membrane-bound proteins
on live cells. J. Am. Chem. Soc. 134, 3961–3964.
Gaietta, G., Deerinck, T.J., Adams, S.R., Bouwer, J., Tour, O., Laird, D.W.,
Sosinsky, G.E., Tsien, R.Y., and Ellisman, M.H. (2002). Multicolor and electron
microscopic imaging of connexin trafficking. Science 296, 503–507.
Griffin, B.A., Adams, S.R., and Tsien, R.Y. (1998). Specific covalent labeling of
recombinant protein molecules inside live cells. Science 281, 269–272.
Grimwood, S., Le Bourdelle`s, B., and Whiting, P.J. (1995). Recombinant hu-
man NMDA homomeric NR1 receptors expressed in mammalian cells form a
high-affinity glycine antagonist binding site. J. Neurochem. 64, 525–530.
Hare, J.F., and Taylor, K. (1991). Mechanisms of plasma membrane protein
degradation: recycling proteins are degraded more rapidly than those
confined to the cell surface. Proc. Natl. Acad. Sci. USA 88, 5902–5906.
Hayashi, T., and Hamachi, I. (2012). Traceless affinity labeling of endogenous
proteins for functional analysis in living cells. Acc. Chem. Res. 45, 1460–1469.
Howl, J. (1999). Fluorescent and biotinylated probes for B2 bradykinin recep-
tors: agonists and antagonists. Peptides 20, 515–518.
Ivanov, S.V., Kuzmin, I., Wei, M.H., Pack, S., Geil, L., Johnson, B.E.,
Stanbridge, E.J., and Lerman, M.I. (1998). Down-regulation of transmembrane
carbonic anhydrases in renal cell carcinoma cell lines by wild-type von Hippel-
Lindau transgenes. Proc. Natl. Acad. Sci. USA 95, 12596–12601.
Jansens, A., and Braakman, I. (2003). Pulse-chase labeling techniques for the
analysis of protein maturation and degradation. In Protein Misfolding and
Diease, P. Bross and N. Gregersen, eds. (Totowa, NJ: Humana Press),
pp. 133–145.
Kamen, B.A., and Capdevila, A. (1986). Receptor-mediated folate accumula-
tion is regulated by the cellular folate content. Proc. Natl. Acad. Sci. USA 83,
5983–5987.
Kane, M.A., Elwood, P.C., Portillo, R.M., Antony, A.C., and Kolhouse, J.F.
(1986). The interrelationship of the soluble and membrane-associated folate-
binding proteins in human KB cells. J. Biol. Chem. 261, 15625–15631.
Keppler, A., Gendreizig, S., Gronemeyer, T., Pick, H., Vogel, H., and Johnsson,
K. (2003). A general method for the covalent labeling of fusion proteins with
small molecules in vivo. Nat. Biotechnol. 21, 86–89.
Kolb, H.C., Finn, M.G., and Sharpless, K.B. (2001). Click Chemistry: Diverse
Chemical Function from a Few Good Reactions. Angew. Chem. Int. Ed.
Engl. 40, 2004–2021.
Li, N., Lim, R.K.V., Edwardraja, S., and Lin, Q. (2011). Copper-free
Sonogashira cross-coupling for functionalization of alkyne-encoded proteins
in aqueous medium and in bacterial cells. J. Am. Chem. Soc. 133, 15316–
15319.
Lippincott-Schwartz, J., and Patterson, G.H. (2003). Development and use of
fluorescent protein markers in living cells. Science 300, 87–91.Chemistry & Biology 21, 1013–Los, G.V., Encell, L.P., McDougall, M.G., Hartzell, D.D., Karassina, N.,
Zimprich, C., Wood, M.G., Learish, R., Ohana, R.F., Urh, M., et al. (2008).
HaloTag: a novel protein labeling technology for cell imaging and protein anal-
ysis. ACS Chem. Biol. 3, 373–382.
Marceau, F., and Regoli, D. (2004). Bradykinin receptor ligands: therapeutic
perspectives. Nat. Rev. Drug Discov. 3, 845–852.
Matsuo, K., Kioi, Y., Yasui, R., Takaoka, Y., Miki, T., Fujishima, S., and
Hamachi, I. (2013). One-step construction of caged carbonic anhydrase I using
a ligand-directed acyl imidazole-based protein labeling method. Chem. Sci. 4,
2573–2580.
Michineau, S., Alhenc-Gelas, F., andRajerison, R.M. (2006). Human bradykinin
B2 receptor sialylation and N-glycosylation participate with disulfide bonding
in surface receptor dimerization. Biochemistry 45, 2699–2707.
Mizukami, S., Watanabe, S., Akimoto, Y., and Kikuchi, K. (2012). No-wash pro-
tein labeling with designed fluorogenic probes and application to real-time
pulse-chase analysis. J. Am. Chem. Soc. 134, 1623–1629.
Moriyoshi, K., Masu, M., Ishii, T., Shigemoto, R., Mizuno, N., and Nakanishi, S.
(1991). Molecular cloning and characterization of the rat NMDA receptor.
Nature 354, 31–37.
Nonaka, H., Fujishima, S.H., Uchinomiya, S.H., Ojida, A., and Hamachi, I.
(2010). Selective covalent labeling of tag-fused GPCR proteins on live cell sur-
face with a synthetic probe for their functional analysis. J. Am. Chem. Soc. 132,
9301–9309.
Overington, J.P., Al-Lazikani, B., and Hopkins, A.L. (2006). Howmany drug tar-
gets are there? Nat. Rev. Drug Discov. 5, 993–996.
Paoletti, P., Bellone, C., and Zhou, Q. (2013). NMDA receptor subunit diversity:
impact on receptor properties, synaptic plasticity and disease. Nat. Rev.
Neurosci. 14, 383–400.
Pizard, A., Blaukat, A., Mu¨ller-Esterl, W., Alhenc-Gelas, F., and Rajerison, R.M.
(1999). Bradykinin-induced internalization of the human B2 receptor requires
phosphorylation of three serine and two threonine residues at its carboxyl
tail. J. Biol. Chem. 274, 12738–12747.
Regoli, D., Nsa Allogho, S., Rizzi, A., and Gobeil, F.J. (1998). Bradykinin recep-
tors and their antagonists. Eur. J. Pharmacol. 348, 1–10.
Song, W., Wang, Y., Qu, J., and Lin, Q. (2008). Selective functionalization of a
genetically encoded alkene-containing protein via ‘‘photoclick chemistry’’ in
bacterial cells. J. Am. Chem. Soc. 130, 9654–9655.
Spicer, C.D., Triemer, T., and Davis, B.G. (2012). Palladium-mediated cell-sur-
face labeling. J. Am. Chem. Soc. 134, 800–803.
Supuran, C.T. (2008). Carbonic anhydrases: novel therapeutic applications for
inhibitors and activators. Nat. Rev. Drug Discov. 7, 168–181.
Takaoka, Y., Ojida, A., and Hamachi, I. (2013). Protein organic chemistry and
applications for labeling and engineering in live-cell systems. Angew. Chem.
Int. Ed. Engl. 52, 4088–4106.
Tamura, T., Tsukiji, S., and Hamachi, I. (2012). Native FKBP12 engineering by
ligand-directed tosyl chemistry: labeling properties and application to photo-
cross-linking of protein complexes in vitro and in living cells. J. Am. Chem.
Soc. 134, 2216–2226.
Tamura, T., Kioi, Y., Miki, T., Tsukiji, S., and Hamachi, I. (2013). Fluorophore
labeling of native FKBP12 by ligand-directed tosyl chemistry allows detection
of its molecular interactions in vitro and in living cells. J. Am. Chem. Soc. 135,
6782–6785.
Tsukiji, S., Miyagawa, M., Takaoka, Y., Tamura, T., and Hamachi, I. (2009).
Ligand-directed tosyl chemistry for protein labeling in vivo. Nat. Chem. Biol.
5, 341–343.
Tu¨reci, O¨., Sahin, U., Vollmar, E., Siemer, S., Go¨ttert, E., Seitz, G., Parkkila,
A.K., Shah, G.N., Grubb, J.H., Pfreundschuh, M., and Sly, W.S. (1998).
Human carbonic anhydrase XII: cDNA cloning, expression, and chromosomal
localization of a carbonic anhydrase gene that is overexpressed in some renal
cell cancers. Proc. Natl. Acad. Sci. USA 95, 7608–7613.
Vullo, D., Innocenti, A., Nishimori, I., Pastorek, J., Scozzafava, A.,
Pastorekova´, S., and Supuran, C.T. (2005). Carbonic anhydrase inhibitors.
Inhibition of the transmembrane isozyme XII with sulfonamides-a new target1022, August 14, 2014 ª2014 Elsevier Ltd All rights reserved 1021
Chemistry & Biology
Pulse-Chase Analysis of Membrane Proteins by LDAIfor the design of antitumor and antiglaucoma drugs? Bioorg. Med. Chem. Lett.
15, 963–969.
Wang, H., Koshi, Y., Minato, D., Nonaka, H., Kiyonaka, S., Mori, Y., Tsukiji, S.,
and Hamachi, I. (2011). Chemical cell-surface receptor engineering using affin-
ity-guided, multivalent organocatalysts. J. Am. Chem. Soc. 133, 12220–
12228.
Whittington, D.A., Waheed, A., Ulmasov, B., Shah, G.N., Grubb, J.H., Sly,
W.S., and Christianson, D.W. (2001). Crystal structure of the dimeric extracel-
lular domain of human carbonic anhydrase XII, a bitopic membrane protein1022 Chemistry & Biology 21, 1013–1022, August 14, 2014 ª2014 Eloverexpressed in certain cancer tumor cells. Proc. Natl. Acad. Sci. USA 98,
9545–9550.
Wykoff, C.C., Beasley, N.J.P., Watson, P.H., Turner, K.J., Pastorek, J., Sibtain,
A., Wilson, G.D., Turley, H., Talks, K.L., Maxwell, P.H., et al. (2000). Hypoxia-
inducible expression of tumor-associated carbonic anhydrases. Cancer Res.
60, 7075–7083.
Yang, X.Y., Mackins, J.Y., Li, Q.J., and Antony, A.C. (1996). Isolation and char-
acterization of a folate receptor-directed metalloprotease from human
placenta. J. Biol. Chem. 271, 11493–11499.sevier Ltd All rights reserved
